CETIRIZINE

CETIRIZINE was reported 167970 times

CETIRIZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 61 0.8714
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5523 0.7701
2 SWOLLEN JOINT COUNT INCREASED 2334 0.7312
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 485 0.7260
4 CARDIOSPASM 402 0.7204
5 RHEUMATIC FEVER 3169 0.7102
6 PEMPHIGUS 8676 0.6932
7 DUODENAL ULCER PERFORATION 5112 0.6867
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 1335 0.6665
9 LUPUS VULGARIS 821 0.6516
10 C-REACTIVE PROTEIN 575 0.6203
11 HEPATIC ENZYME 92 0.6174
12 RHEUMATOID FACTOR POSITIVE 3471 0.6003
13 IMMUNISATION 257 0.5922
14 GRIP STRENGTH 135 0.5895
15 FACET JOINT SYNDROME 1889 0.5796
16 VAGINAL FLATULENCE 172 0.5677
17 SWOLLEN JOINT COUNT 139 0.5560
18 HAND DEFORMITY 7172 0.5463
19 PALMOPLANTAR KERATODERMA 390 0.5379
20 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1081 0.5212
21 HELICOBACTER INFECTION 5054 0.4913
22 MUSCLE INJURY 3927 0.4735
23 DISLOCATION OF VERTEBRA 1066 0.4669
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2795 0.4299
25 FOLLICULITIS 4437 0.4227
26 X-RAY ABNORMAL 753 0.4207
27 RETINITIS 700 0.4049
28 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 221 0.3939
29 PERICARDITIS 6556 0.3898
30 GLOSSODYNIA 8161 0.3642
31 ANTICIPATORY ANXIETY 99 0.3640
32 SYNOVITIS 6269 0.3473
33 PERIPHERAL VENOUS DISEASE 1410 0.3449
34 SERONEGATIVE ARTHRITIS 348 0.3037
35 HYPOCHOLESTEROLAEMIA 104 0.2946
36 C-REACTIVE PROTEIN ABNORMAL 1703 0.2652
37 SYSTEMIC LUPUS ERYTHEMATOSUS 8883 0.2500
38 WOUND 6912 0.2470
39 BREAST CANCER STAGE III 1569 0.2420
40 CONTRAINDICATED PRODUCT ADMINISTERED 6740 0.2224
41 TEMPERATURE REGULATION DISORDER 470 0.2108
42 LIP DRY 1890 0.2079
43 BONE EROSION 723 0.2042
44 IRRITABLE BOWEL SYNDROME 4368 0.2035
45 PORPHYRIA ACUTE 284 0.1979
46 ATRIAL TACHYCARDIA 405 0.1927
47 POST CHOLECYSTECTOMY SYNDROME 53 0.1873
48 PRURITUS GENITAL 436 0.1850
49 ONYCHOMADESIS 768 0.1828
50 BURSITIS 2219 0.1827
51 CHRONIC SPONTANEOUS URTICARIA 210 0.1810
52 GRIP STRENGTH DECREASED 1566 0.1778
53 OVERLAP SYNDROME 124 0.1771
54 LIVE BIRTH 1460 0.1743
55 HYPERCHOLESTEROLAEMIA 1673 0.1731
56 DRUG TOLERANCE DECREASED 476 0.1693
57 JOINT RANGE OF MOTION DECREASED 2261 0.1684
58 BLEPHAROSPASM 1038 0.1647
59 VOCAL CORD DYSFUNCTION 81 0.1643
60 WOUND INFECTION 1800 0.1642
61 ANKLE ARTHROPLASTY 56 0.1543
62 JOINT DESTRUCTION 222 0.1427
63 AUTOIMMUNE DISORDER 1391 0.1426
64 ELECTRIC SHOCK 118 0.1377
65 FIBROMYALGIA 3325 0.1366
66 NAIL OPERATION 56 0.1353
67 LARYNGEAL STENOSIS 78 0.1349
68 IMPAIRED HEALING 4430 0.1348
69 ONYCHOMYCOSIS 586 0.1334
70 GRANULOCYTE COUNT INCREASED 54 0.1333
71 LIVER INJURY 3156 0.1284
72 ARTHROPATHY 7097 0.1276
73 URTICARIA CHRONIC 66 0.1176
74 DEATH NEONATAL 163 0.1171
75 TYPE 2 DIABETES MELLITUS 3858 0.1145
76 SLEEP TERROR 475 0.1127
77 INFUSION RELATED REACTION 7418 0.1118
78 CAROTID ARTERY OCCLUSION 396 0.1084
79 OBESITY 1728 0.1084
80 FEMALE GENITAL TRACT FISTULA 185 0.1083
81 COELIAC DISEASE 1055 0.1074
82 VICTIM OF CHEMICAL SUBMISSION 71 0.1058
83 NAIL DISORDER 924 0.1055
84 MATERNAL EXPOSURE TIMING UNSPECIFIED 391 0.1040
85 BLOOD IMMUNOGLOBULIN A INCREASED 56 0.1039
86 FINGER DEFORMITY 501 0.1033
87 LOWER RESPIRATORY TRACT INFECTION 4684 0.1029
88 INFUSION SITE REACTION 302 0.1010
89 PERFUME SENSITIVITY 57 0.1002
90 THERAPEUTIC PRODUCT EFFECT DECREASED 4425 0.0987
91 CHRONIC SINUSITIS 368 0.0980
92 DISCOMFORT 5979 0.0979
93 TENSION HEADACHE 420 0.0976
94 PRESCRIBED OVERDOSE 1884 0.0973
95 HEPATIC ENZYME INCREASED 6508 0.0954
96 FOOD ALLERGY 726 0.0940
97 PSORIATIC ARTHROPATHY 3803 0.0936
98 HIP ARTHROPLASTY 1394 0.0909
99 SCIATICA 1444 0.0905
100 BLISTER 5045 0.0897
101 SWELLING 8331 0.0889
102 EXOSTOSIS 794 0.0869
103 WALKING AID USER 546 0.0827
104 RED BLOOD CELL SEDIMENTATION RATE INCREASED 916 0.0827
105 RHEUMATOID ARTHRITIS 9137 0.0804
106 LUPUS-LIKE SYNDROME 699 0.0770
107 PULMONARY FIBROSIS 1455 0.0758
108 URINE LEUKOCYTE ESTERASE POSITIVE 53 0.0757
109 STOMATITIS 4469 0.0736
110 VITAMIN B12 INCREASED 58 0.0728
111 RESTRICTIVE PULMONARY DISEASE 85 0.0725
112 BLOOD CHOLESTEROL INCREASED 3376 0.0723
113 PRODUCT LABEL CONFUSION 422 0.0723
114 LOWER LIMB FRACTURE 1386 0.0721
115 RADICULOPATHY 189 0.0716
116 BLOOD IMMUNOGLOBULIN E INCREASED 173 0.0714
117 PROCTITIS 197 0.0703
118 MATERNAL EXPOSURE DURING PREGNANCY 6209 0.0696
119 MAST CELL ACTIVATION SYNDROME 96 0.0684
120 MACULAR DEGENERATION 813 0.0680
121 DRUG INTOLERANCE 6508 0.0673
122 KNEE ARTHROPLASTY 1414 0.0671
123 PUSTULAR PSORIASIS 229 0.0666
124 GLOMERULAR FILTRATION RATE INCREASED 55 0.0666
125 BACK INJURY 722 0.0663
126 INTERVERTEBRAL DISCITIS 124 0.0657
127 FOOT DEFORMITY 727 0.0655
128 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 389 0.0639
129 JOINT DISLOCATION 672 0.0635
130 BREAST CANCER STAGE II 527 0.0633
131 NIGHT SWEATS 2041 0.0633
132 CONGENITAL ANOMALY 490 0.0632
133 JOINT SWELLING 7423 0.0614
134 FORCED EXPIRATORY VOLUME DECREASED 174 0.0614
135 GAIT INABILITY 2049 0.0612
136 DACTYLITIS 60 0.0611
137 WHEEZING 3575 0.0602
138 SPONDYLITIS 218 0.0599
139 ILL-DEFINED DISORDER 3547 0.0583
140 ABDOMINAL DISCOMFORT 9786 0.0583
141 FOETAL DEATH 302 0.0582
142 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 134 0.0581
143 EYE INJURY 176 0.0579
144 DRUG TOLERANCE 293 0.0579
145 IMMUNODEFICIENCY 831 0.0557
146 ULCER HAEMORRHAGE 375 0.0554
147 NONINFECTIVE GINGIVITIS 79 0.0545
148 PRESCRIBED UNDERDOSE 1082 0.0542
149 FACIAL PAIN 482 0.0539
150 WHITE BLOOD CELLS URINE POSITIVE 101 0.0536
151 OSTEOARTHRITIS 2270 0.0535
152 RASH VESICULAR 256 0.0529
153 TREATMENT FAILURE 4280 0.0516
154 RHEUMATOID FACTOR INCREASED 56 0.0501
155 TASTE DISORDER 1009 0.0497
156 ALOPECIA 9649 0.0491
157 MOBILITY DECREASED 3473 0.0483
158 SUBARACHNOID HAEMORRHAGE 479 0.0470
159 C-REACTIVE PROTEIN INCREASED 1705 0.0468
160 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 332 0.0463
161 PULMONARY PAIN 134 0.0459
162 INJURY 3225 0.0458
163 SINUSITIS 4627 0.0451
164 EXPOSURE DURING PREGNANCY 2781 0.0447
165 NORMAL NEWBORN 243 0.0447
166 INFLAMMATION 2297 0.0445
167 HYPERSENSITIVITY 8229 0.0443
168 GASTROINTESTINAL DISORDER 3891 0.0434
169 SLEEP DISORDER 3064 0.0434
170 EPILEPSY 1318 0.0431
171 LIVER FUNCTION TEST INCREASED 921 0.0429
172 EAR PAIN 830 0.0427
173 INTENTIONAL PRODUCT USE ISSUE 3707 0.0423
174 MUSCULOSKELETAL STIFFNESS 3682 0.0420
175 OEDEMA 2254 0.0415
176 HEPATIC CIRRHOSIS 780 0.0415
177 CHRONIC FATIGUE SYNDROME 57 0.0409
178 GENERAL PHYSICAL HEALTH DETERIORATION 4689 0.0405
179 INFUSION SITE DISCHARGE 71 0.0405
180 POLYARTHRITIS 213 0.0404
181 LUNG DISORDER 1951 0.0398
182 VASCULITIS 460 0.0394
183 ROAD TRAFFIC ACCIDENT 1611 0.0385
184 SPINAL FUSION SURGERY 156 0.0384
185 BRONCHIAL DISORDER 58 0.0373
186 URTICARIA 6245 0.0372
187 NASAL DISCHARGE DISCOLOURATION 51 0.0370
188 CONTUSION 3525 0.0366
189 OBSTRUCTIVE AIRWAYS DISORDER 407 0.0366
190 PREGNANCY 727 0.0363
191 DELIRIUM 1260 0.0363
192 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 605 0.0353
193 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 599 0.0352
194 PERIPHERAL SWELLING 5427 0.0352
195 MUSCLE SPASTICITY 429 0.0349
196 EAR INFECTION 919 0.0345
197 DRUG-INDUCED LIVER INJURY 1082 0.0345
198 FIXED ERUPTION 59 0.0343
199 LIVER DISORDER 1519 0.0342
200 DRY MOUTH 2776 0.0342
201 ASPARTATE AMINOTRANSFERASE ABNORMAL 52 0.0341
202 INFECTION 4907 0.0339
203 ANGIOEDEMA 1476 0.0333
204 ORAL PRURITUS 76 0.0331
205 MUSCULOSKELETAL PAIN 1718 0.0328
206 JOINT NOISE 64 0.0326
207 ANOSMIA 466 0.0322
208 APLASTIC ANAEMIA 167 0.0319
209 ADRENAL INSUFFICIENCY 388 0.0319
210 ASTHMA 3609 0.0319
211 MONOCYTE COUNT INCREASED 113 0.0311
212 DEMYELINATION 127 0.0310
213 THERAPY NON-RESPONDER 1385 0.0308
214 JOINT STIFFNESS 801 0.0305
215 LABYRINTHITIS 77 0.0304
216 RESPIRATORY DISORDER 907 0.0303
217 MEAN CELL HAEMOGLOBIN DECREASED 55 0.0300
218 CONFUSIONAL STATE 4856 0.0300
219 PRODUCT USE ISSUE 5603 0.0298
220 ADVERSE REACTION 391 0.0295
221 MYOSITIS 262 0.0292
222 UPPER RESPIRATORY TRACT INFECTION 1339 0.0290
223 PARAESTHESIA ORAL 416 0.0288
224 NASOPHARYNGITIS 5311 0.0288
225 MIGRAINE 2714 0.0284
226 BACTERIAL TEST POSITIVE 63 0.0282
227 LIP SWELLING 930 0.0279
228 BLOOD PRESSURE DIASTOLIC ABNORMAL 69 0.0271
229 DISABILITY 536 0.0271
230 BODY TEMPERATURE INCREASED 551 0.0270
231 GENERAL SYMPTOM 202 0.0269
232 TYPE I HYPERSENSITIVITY 94 0.0267
233 INFUSION SITE PRURITUS 84 0.0266
234 AMNESIA 1721 0.0264
235 VENTRICULAR TACHYCARDIA 435 0.0263
236 THROAT CLEARING 98 0.0261
237 RHINITIS ALLERGIC 115 0.0258
238 POST-TRAUMATIC STRESS DISORDER 172 0.0256
239 SKIN PLAQUE 216 0.0256
240 MUSCLE TWITCHING 589 0.0255
241 HYPOAESTHESIA 3824 0.0255
242 OSTEITIS 64 0.0253
243 RESPIRATORY SYMPTOM 72 0.0253
244 DYSPEPSIA 2429 0.0247
245 HEPATITIS 621 0.0242
246 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1161 0.0241
247 RASH 10497 0.0241
248 BLOOD PRESSURE DIASTOLIC INCREASED 111 0.0240
249 HYPERTENSION 5080 0.0240
250 SEASONAL ALLERGY 337 0.0238
251 SUSPECTED OFF LABEL USE 107 0.0237
252 WEIGHT INCREASED 5301 0.0236
253 INFUSION SITE HAEMORRHAGE 77 0.0234
254 BLOOD PRESSURE SYSTOLIC ABNORMAL 57 0.0230
255 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1612 0.0226
256 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 123 0.0226
257 HYPERPARATHYROIDISM SECONDARY 56 0.0223
258 RHINITIS 180 0.0223
259 OSTEOPOROSIS 909 0.0221
260 SCRATCH 229 0.0217
261 FREQUENT BOWEL MOVEMENTS 585 0.0216
262 TEMPERATURE INTOLERANCE 222 0.0215
263 RHINOVIRUS INFECTION 83 0.0213
264 EYE PRURITUS 710 0.0211
265 PRURITUS 8105 0.0211
266 MUSCULAR WEAKNESS 2393 0.0210
267 VAGINAL DISCHARGE 212 0.0209
268 SENSITIVITY TO WEATHER CHANGE 110 0.0209
269 WEIGHT FLUCTUATION 217 0.0207
270 PAIN 12721 0.0207
271 MOUTH SWELLING 117 0.0203
272 VITAMIN B12 DEFICIENCY 82 0.0202
273 ABDOMINAL PAIN UPPER 4145 0.0201
274 VITAMIN B12 DECREASED 58 0.0201
275 GASTROOESOPHAGEAL REFLUX DISEASE 1619 0.0201
276 URINE ANALYSIS ABNORMAL 60 0.0200
277 BLOOD PRESSURE DIASTOLIC DECREASED 147 0.0199
278 LOOSE TOOTH 64 0.0198
279 CONDITION AGGRAVATED 6019 0.0198
280 ORAL CANDIDIASIS 260 0.0197
281 ARTHRALGIA 8050 0.0193
282 PYREXIA 6560 0.0189
283 MEMORY IMPAIRMENT 2593 0.0189
284 DIPLOPIA 490 0.0188
285 DRUG USE DISORDER 158 0.0188
286 INFUSION SITE SWELLING 118 0.0187
287 PHARYNGEAL SWELLING 182 0.0186
288 MIDDLE INSOMNIA 346 0.0185
289 REBOUND ACID HYPERSECRETION 56 0.0185
290 MULTIPLE ALLERGIES 145 0.0185
291 PAIN OF SKIN 497 0.0184
292 BLOOD PRESSURE SYSTOLIC INCREASED 359 0.0184
293 NEPHROGENIC ANAEMIA 85 0.0183
294 RASH ERYTHEMATOUS 876 0.0183
295 NECK PAIN 1019 0.0182
296 PARANASAL SINUS DISCOMFORT 68 0.0179
297 BACK DISORDER 290 0.0178
298 ATTENTION DEFICIT HYPERACTIVITY DISORDER 75 0.0178
299 FATIGUE 13707 0.0176
300 FLUID RETENTION 893 0.0175
301 ADVERSE DRUG REACTION 1576 0.0175
302 MEDICATION ERROR 974 0.0175
303 SPUTUM DISCOLOURED 166 0.0175
304 SYMPTOM RECURRENCE 104 0.0174
305 URINE ABNORMALITY 79 0.0174
306 BLOOD PRESSURE SYSTOLIC DECREASED 79 0.0174
307 ANAPHYLACTIC REACTION 958 0.0173
308 COORDINATION ABNORMAL 241 0.0173
309 RASH PAPULAR 387 0.0172
310 MATERNAL EXPOSURE DURING BREAST FEEDING 69 0.0170
311 CYSTIC FIBROSIS 93 0.0168
312 INFUSION SITE ERYTHEMA 139 0.0165
313 FOOD INTOLERANCE 60 0.0164
314 ADVERSE EVENT 1506 0.0163
315 PULMONARY FUNCTION TEST DECREASED 71 0.0162
316 PAPULE 114 0.0162
317 HALLUCINATIONS, MIXED 68 0.0162
318 INFUSION SITE PAIN 206 0.0160
319 PARAESTHESIA 2474 0.0157
320 COGNITIVE DISORDER 728 0.0156
321 INSOMNIA 4152 0.0156
322 TACHYCARDIA 1383 0.0156
323 FOOT OPERATION 77 0.0155
324 EOSINOPHILIA 272 0.0155
325 CHEST PAIN 2868 0.0155
326 PRODUCT ADMINISTRATION INTERRUPTED 120 0.0153
327 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 126 0.0153
328 UPPER-AIRWAY COUGH SYNDROME 125 0.0152
329 DISTURBANCE IN ATTENTION 816 0.0151
330 GASTROENTERITIS VIRAL 273 0.0151
331 TRANSIENT ISCHAEMIC ATTACK 509 0.0151
332 ARTHRITIS 1183 0.0150
333 EOSINOPHIL COUNT INCREASED 125 0.0150
334 FULL BLOOD COUNT ABNORMAL 158 0.0149
335 BODY TEMPERATURE DECREASED 146 0.0148
336 SOMNAMBULISM 96 0.0146
337 WHEELCHAIR USER 65 0.0146
338 CYTOKINE RELEASE SYNDROME 293 0.0146
339 BREATH SOUNDS ABNORMAL 72 0.0146
340 SNORING 55 0.0145
341 RECTAL HAEMORRHAGE 625 0.0145
342 PERIORBITAL SWELLING 82 0.0145
343 VITAMIN D DEFICIENCY 140 0.0143
344 PRODUCTIVE COUGH 684 0.0143
345 INTENTIONAL PRODUCT MISUSE 1245 0.0142
346 RED CELL DISTRIBUTION WIDTH INCREASED 59 0.0142
347 CUTANEOUS VASCULITIS 51 0.0140
348 BRONCHIECTASIS 94 0.0139
349 ANGIOPATHY 78 0.0139
350 PRODUCT USE IN UNAPPROVED INDICATION 3445 0.0139
351 COLITIS ULCERATIVE 621 0.0139
352 TINNITUS 635 0.0138
353 DYSPNOEA 7808 0.0138
354 FEELING HOT 837 0.0136
355 HYPERTRANSAMINASAEMIA 94 0.0135
356 HYPERHIDROSIS 1735 0.0135
357 DECREASED APPETITE 3127 0.0134
358 SYNOVIAL CYST 62 0.0134
359 DEPRESSION 3053 0.0134
360 ULCER 213 0.0134
361 FLANK PAIN 125 0.0133
362 OEDEMA PERIPHERAL 1625 0.0133
363 SINUS DISORDER 264 0.0133
364 NASAL CONGESTION 782 0.0133
365 MUSCLE SPASMS 2439 0.0133
366 SPINAL DISORDER 124 0.0131
367 FOOD POISONING 70 0.0131
368 OROPHARYNGEAL DISCOMFORT 118 0.0131
369 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 101 0.0130
370 PHARYNGITIS 161 0.0130
371 THROAT IRRITATION 582 0.0130
372 SINUS CONGESTION 175 0.0129
373 SECRETION DISCHARGE 162 0.0129
374 HEADACHE 8100 0.0129
375 PRE-EXISTING CONDITION IMPROVED 80 0.0128
376 SWOLLEN TONGUE 398 0.0127
377 MALAISE 5551 0.0126
378 SLEEP APNOEA SYNDROME 240 0.0126
379 VOMITING 5908 0.0126
380 NEUTROPHIL COUNT INCREASED 128 0.0125
381 WHITE BLOOD CELL COUNT INCREASED 479 0.0125
382 MATERNAL EXPOSURE BEFORE PREGNANCY 85 0.0124
383 BRONCHITIS 919 0.0124
384 ARTHROPOD BITE 92 0.0124
385 NODULE 162 0.0124
386 SKIN WARM 72 0.0124
387 DERMATITIS CONTACT 140 0.0123
388 SKIN LESION 335 0.0122
389 PROCTALGIA 78 0.0121
390 VISUAL IMPAIRMENT 1503 0.0121
391 HEART RATE INCREASED 1200 0.0121
392 PNEUMONIA 3908 0.0121
393 INJECTION SITE REACTION 829 0.0120
394 CHOLECYSTITIS ACUTE 68 0.0120
395 SWELLING FACE 781 0.0120
396 INCORRECT DRUG ADMINISTRATION RATE 51 0.0120
397 BLOOD URIC ACID INCREASED 69 0.0119
398 BLINDNESS 485 0.0119
399 JOINT EFFUSION 82 0.0119
400 INFUSION SITE EXTRAVASATION 74 0.0119
401 TOOTH FRACTURE 131 0.0119
402 RALES 69 0.0119
403 ANXIETY 3375 0.0118
404 SKIN ABRASION 56 0.0118
405 ABDOMINAL PAIN 2750 0.0118
406 IMMUNE THROMBOCYTOPENIA 54 0.0118
407 MYDRIASIS 151 0.0118
408 THERAPEUTIC RESPONSE DECREASED 712 0.0117
409 HYPERVENTILATION 68 0.0117
410 OFF LABEL USE 10234 0.0117
411 IMPAIRED QUALITY OF LIFE 167 0.0116
412 SKIN REACTION 163 0.0116
413 GAIT DISTURBANCE 2188 0.0114
414 PROCEDURAL PAIN 315 0.0113
415 MIOSIS 91 0.0113
416 RASH PRURITIC 614 0.0113
417 DECREASED IMMUNE RESPONSIVENESS 111 0.0113
418 HYPOKALAEMIA 519 0.0112
419 RASH MACULO-PAPULAR 250 0.0112
420 SNEEZING 250 0.0111
421 BRUXISM 60 0.0111
422 THROAT TIGHTNESS 299 0.0110
423 TENDON DISORDER 72 0.0110
424 RESPIRATORY RATE INCREASED 98 0.0110
425 LYMPHOCYTE COUNT DECREASED 195 0.0110
426 RESPIRATORY SYNCYTIAL VIRUS INFECTION 96 0.0110
427 SWELLING OF EYELID 69 0.0110
428 WRONG PRODUCT ADMINISTERED 74 0.0109
429 DIZZINESS 5457 0.0109
430 EXPIRED PRODUCT ADMINISTERED 363 0.0109
431 PAIN IN EXTREMITY 3215 0.0109
432 CHEST DISCOMFORT 1109 0.0108
433 HALLUCINATION 809 0.0107
434 DERMATITIS ALLERGIC 135 0.0107
435 NASAL DRYNESS 67 0.0107
436 SMALL FOR DATES BABY 53 0.0107
437 ASTHENIA 4000 0.0106
438 SINUS HEADACHE 63 0.0106
439 JOINT INJURY 226 0.0106
440 ECZEMA 553 0.0106
441 TONSILLITIS 55 0.0105
442 OXYGEN SATURATION DECREASED 592 0.0105
443 PIGMENTATION DISORDER 65 0.0105
444 RESPIRATORY TRACT INFECTION 274 0.0105
445 BLOOD PRESSURE FLUCTUATION 252 0.0105
446 HEPATITIS ACUTE 68 0.0105
447 DRUG INEFFECTIVE 13752 0.0104
448 BRAIN FOG 163 0.0104
449 RESPIRATORY TRACT CONGESTION 164 0.0103
450 TOXIC EPIDERMAL NECROLYSIS 156 0.0103
451 ABDOMINAL TENDERNESS 51 0.0103
452 ABDOMINAL DISTENSION 1069 0.0102
453 PHOTOSENSITIVITY REACTION 168 0.0102
454 DIARRHOEA 6552 0.0101
455 PSORIASIS 1319 0.0101
456 UNDERDOSE 736 0.0101
457 WEIGHT DECREASED 2810 0.0101
458 DEPRESSED MOOD 532 0.0101
459 BLOOD CALCIUM DECREASED 113 0.0100
460 PALPITATIONS 1176 0.0100
461 IMPAIRED GASTRIC EMPTYING 136 0.0100
462 BACK PAIN 2314 0.0100
463 RHINORRHOEA 643 0.0099
464 ERYTHEMA 2043 0.0099
465 EYE SWELLING 367 0.0099
466 HYPERTHERMIA 75 0.0098
467 LIMB DISCOMFORT 302 0.0098
468 BREAST MASS 65 0.0097
469 AFFECTIVE DISORDER 76 0.0097
470 FRUSTRATION TOLERANCE DECREASED 78 0.0096
471 COVID-19 1690 0.0096
472 OROPHARYNGEAL PAIN 891 0.0096
473 BRONCHOSPASM 137 0.0096
474 STREPTOCOCCAL INFECTION 53 0.0095
475 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 245 0.0095
476 RETCHING 203 0.0095
477 HEART RATE ABNORMAL 53 0.0095
478 FACE OEDEMA 160 0.0095
479 PRURITUS GENERALISED 205 0.0095
480 ANAPHYLACTIC SHOCK 244 0.0095
481 LACRIMATION INCREASED 285 0.0094
482 SKIN INFECTION 105 0.0094
483 LABORATORY TEST ABNORMAL 275 0.0093
484 THERAPY PARTIAL RESPONDER 145 0.0093
485 WITHDRAWAL SYNDROME 390 0.0093
486 POOR VENOUS ACCESS 96 0.0093
487 CONJUNCTIVITIS 172 0.0093
488 NAUSEA 7327 0.0092
489 HEREDITARY ANGIOEDEMA 99 0.0092
490 RASH MACULAR 322 0.0092
491 BLOOD TEST ABNORMAL 129 0.0092
492 VIRAL INFECTION 305 0.0092
493 COUGH 2568 0.0091
494 GASTROENTERITIS 132 0.0090
495 BLOOD MAGNESIUM DECREASED 78 0.0090
496 APHONIA 126 0.0090
497 SKIN HAEMORRHAGE 133 0.0090
498 PHARYNGITIS STREPTOCOCCAL 97 0.0090
499 TOOTH ABSCESS 91 0.0089
500 TENDERNESS 93 0.0089
501 HYPOCALCAEMIA 168 0.0089
502 DYSPNOEA EXERTIONAL 334 0.0089
503 EXERCISE TOLERANCE DECREASED 51 0.0089
504 HYPOMAGNESAEMIA 123 0.0088
505 PETECHIAE 92 0.0088
506 CHRONIC KIDNEY DISEASE 664 0.0087
507 END STAGE RENAL DISEASE 159 0.0087
508 POISONING 109 0.0087
509 ASPIRATION 95 0.0087
510 ILLNESS 892 0.0086
511 POOR QUALITY SLEEP 186 0.0086
512 SLUGGISHNESS 88 0.0086
513 SOMNOLENCE 1735 0.0086
514 HEPATOCELLULAR INJURY 121 0.0085
515 RESTLESS LEGS SYNDROME 155 0.0085
516 MUCOSAL INFLAMMATION 223 0.0085
517 FEBRILE NEUTROPENIA 558 0.0084
518 DRY EYE 418 0.0084
519 PURPURA 74 0.0084
520 ERYTHEMA MULTIFORME 78 0.0084
521 COLITIS 317 0.0084
522 QUALITY OF LIFE DECREASED 112 0.0083
523 UROSEPSIS 77 0.0083
524 DECREASED ACTIVITY 89 0.0082
525 BLOOD UREA INCREASED 138 0.0082
526 FEELING DRUNK 61 0.0082
527 FOETAL EXPOSURE DURING PREGNANCY 666 0.0082
528 SARS-COV-2 TEST POSITIVE 108 0.0082
529 THERAPEUTIC RESPONSE SHORTENED 271 0.0082
530 INCORRECT PRODUCT ADMINISTRATION DURATION 177 0.0082
531 DYSPHAGIA 773 0.0081
532 THROMBOCYTOPENIA 909 0.0081
533 DIZZINESS POSTURAL 78 0.0080
534 TOXIC SKIN ERUPTION 81 0.0080
535 GINGIVAL PAIN 64 0.0080
536 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 439 0.0080
537 LIGAMENT SPRAIN 79 0.0080
538 EAR DISCOMFORT 82 0.0080
539 NEUTROPENIC SEPSIS 57 0.0080
540 OBSESSIVE-COMPULSIVE DISORDER 64 0.0080
541 ACCIDENTAL OVERDOSE 291 0.0079
542 JAUNDICE 214 0.0079
543 BLOOD PRESSURE INCREASED 1209 0.0079
544 PRESYNCOPE 192 0.0079
545 ACCIDENT 94 0.0079
546 APPETITE DISORDER 52 0.0078
547 RESPIRATION ABNORMAL 54 0.0078
548 DROOLING 54 0.0078
549 CONSTIPATION 1693 0.0078
550 DYSPHONIA 453 0.0077
551 PANCREATITIS 409 0.0077
552 DERMATITIS BULLOUS 56 0.0077
553 DRUG ERUPTION 137 0.0077
554 SENSITIVE SKIN 57 0.0077
555 COVID-19 PNEUMONIA 91 0.0077
556 NERVE COMPRESSION 71 0.0077
557 DERMATITIS ATOPIC 405 0.0077
558 INTERVERTEBRAL DISC DEGENERATION 71 0.0077
559 INFLUENZA 852 0.0076
560 EMPHYSEMA 77 0.0076
561 APHTHOUS ULCER 59 0.0076
562 PHARYNGEAL OEDEMA 117 0.0076
563 MOUTH ULCERATION 160 0.0076
564 IRON DEFICIENCY ANAEMIA 70 0.0076
565 DRUG EFFECT LESS THAN EXPECTED 112 0.0076
566 SCAB 86 0.0075
567 DRY THROAT 76 0.0075
568 NIGHTMARE 258 0.0074
569 PEMPHIGOID 56 0.0074
570 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1333 0.0074
571 POISONING DELIBERATE 70 0.0074
572 MUSCULOSKELETAL DISCOMFORT 127 0.0074
573 ORAL HERPES 144 0.0074
574 SKIN SWELLING 64 0.0074
575 PLATELET COUNT INCREASED 96 0.0074
576 GINGIVAL BLEEDING 100 0.0073
577 ALANINE AMINOTRANSFERASE INCREASED 448 0.0073
578 STEVENS-JOHNSON SYNDROME 162 0.0073
579 HAEMATOCHEZIA 400 0.0072
580 HYPOAESTHESIA ORAL 109 0.0072
581 PHOTOPHOBIA 136 0.0072
582 INSURANCE ISSUE 110 0.0072
583 HEAD DISCOMFORT 127 0.0072
584 PAROSMIA 54 0.0071
585 PRODUCT QUALITY ISSUE 972 0.0071
586 BLOOD COUNT ABNORMAL 108 0.0071
587 DRY SKIN 950 0.0071
588 HEART RATE DECREASED 248 0.0071
589 INTENTIONAL DOSE OMISSION 201 0.0070
590 ATRIAL SEPTAL DEFECT 59 0.0070
591 SINUS TACHYCARDIA 100 0.0070
592 PRODUCT DISTRIBUTION ISSUE 65 0.0070
593 CONCUSSION 54 0.0070
594 ORAL PAIN 156 0.0070
595 SENSORY LOSS 56 0.0069
596 HEPATIC CYTOLYSIS 88 0.0069
597 SENSATION OF FOREIGN BODY 58 0.0069
598 TRANSFUSION 72 0.0069
599 DEHYDRATION 916 0.0069
600 CHOKING 133 0.0068
601 BLOOD ALKALINE PHOSPHATASE INCREASED 169 0.0068
602 URINARY RETENTION 227 0.0068
603 DRUG ABUSE 565 0.0068
604 RED BLOOD CELL COUNT DECREASED 194 0.0068
605 CHROMATURIA 153 0.0068
606 GLOMERULAR FILTRATION RATE DECREASED 83 0.0067
607 URINARY INCONTINENCE 200 0.0067
608 PSYCHOMOTOR HYPERACTIVITY 112 0.0067
609 PRODUCT DOSE OMISSION IN ERROR 191 0.0067
610 ASPARTATE AMINOTRANSFERASE INCREASED 358 0.0067
611 TUBULOINTERSTITIAL NEPHRITIS 126 0.0067
612 BALANCE DISORDER 581 0.0067
613 OSTEOPENIA 102 0.0067
614 HIATUS HERNIA 87 0.0067
615 GOUT 120 0.0067
616 BOWEL MOVEMENT IRREGULARITY 51 0.0067
617 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 346 0.0066
618 HYPERSOMNIA 190 0.0066
619 INITIAL INSOMNIA 68 0.0066
620 FEELING COLD 183 0.0066
621 MICTURITION URGENCY 75 0.0066
622 PARANOIA 113 0.0065
623 LIMB INJURY 178 0.0065
624 REBOUND EFFECT 74 0.0065
625 VERTIGO 399 0.0065
626 GASTROINTESTINAL PAIN 72 0.0065
627 SENSORY DISTURBANCE 105 0.0065
628 BLOOD POTASSIUM DECREASED 196 0.0065
629 OCULAR DISCOMFORT 73 0.0065
630 INTENTIONAL SELF-INJURY 131 0.0065
631 LEUKOPENIA 324 0.0065
632 DYSARTHRIA 243 0.0064
633 ACUTE RESPIRATORY FAILURE 124 0.0064
634 ACUTE KIDNEY INJURY 985 0.0064
635 THIRST 115 0.0064
636 LYMPHADENOPATHY 227 0.0064
637 DRUG INTERACTION 1014 0.0064
638 CHILLS 749 0.0064
639 HYPOXIA 225 0.0064
640 FEELING ABNORMAL 1530 0.0064
641 FALL 2122 0.0064
642 HYPONATRAEMIA 359 0.0064
643 EYE DISORDER 209 0.0064
644 ANHEDONIA 167 0.0063
645 MYASTHENIA GRAVIS 51 0.0063
646 ELECTROCARDIOGRAM QT PROLONGED 227 0.0063
647 TOOTH INFECTION 83 0.0063
648 CANDIDA INFECTION 106 0.0063
649 BLOOD URINE PRESENT 119 0.0063
650 KIDNEY INFECTION 123 0.0063
651 SPINAL OSTEOARTHRITIS 55 0.0063
652 HYPOTHERMIA 63 0.0062
653 SINUS BRADYCARDIA 60 0.0062
654 HAEMATOCRIT DECREASED 123 0.0062
655 OVERDOSE 1338 0.0062
656 INCREASED TENDENCY TO BRUISE 57 0.0062
657 LETHARGY 356 0.0062
658 FOOT FRACTURE 117 0.0062
659 HYPOTENSION 1236 0.0062
660 DISORIENTATION 244 0.0062
661 SYNCOPE 614 0.0061
662 AGEUSIA 153 0.0061
663 HYPOTONIA 61 0.0061
664 PANIC ATTACK 222 0.0061
665 DYSURIA 224 0.0061
666 MANIA 100 0.0061
667 CYSTITIS 193 0.0061
668 SEIZURE 698 0.0060
669 HAEMOPTYSIS 168 0.0060
670 ANGER 203 0.0060
671 PNEUMONITIS 163 0.0060
672 AGITATION 439 0.0060
673 BLOOD PRESSURE DECREASED 397 0.0060
674 FUNGAL INFECTION 199 0.0060
675 HEPATIC STEATOSIS 111 0.0060
676 SUPRAVENTRICULAR TACHYCARDIA 57 0.0059
677 ANKLE FRACTURE 92 0.0059
678 MASS 83 0.0059
679 PRODUCT ADMINISTRATION ERROR 120 0.0059
680 SEPTIC SHOCK 258 0.0059
681 PANCREATITIS ACUTE 133 0.0059
682 FLUSHING 601 0.0059
683 BLOOD IRON DECREASED 70 0.0059
684 AGGRESSION 295 0.0059
685 TACHYPNOEA 80 0.0059
686 URINARY TRACT INFECTION 1000 0.0059
687 INTERVERTEBRAL DISC PROTRUSION 128 0.0058
688 CARPAL TUNNEL SYNDROME 82 0.0058
689 HAEMORRHOIDS 114 0.0058
690 PULMONARY MASS 87 0.0058
691 BLOOD SODIUM DECREASED 110 0.0058
692 EXTRA DOSE ADMINISTERED 236 0.0058
693 SUICIDAL IDEATION 531 0.0058
694 LYMPHOPENIA 82 0.0058
695 RESTLESSNESS 212 0.0058
696 LOSS OF CONSCIOUSNESS 740 0.0058
697 NEURALGIA 140 0.0058
698 PRODUCT DOSE OMISSION ISSUE 1692 0.0057
699 PERIPHERAL COLDNESS 79 0.0057
700 GASTRITIS 151 0.0057
701 HYPERKALAEMIA 201 0.0057
702 CRYING 208 0.0057
703 PULMONARY CONGESTION 75 0.0057
704 MUSCLE TIGHTNESS 92 0.0057
705 FEELING JITTERY 108 0.0057
706 SEDATION 148 0.0056
707 CIRCULATORY COLLAPSE 96 0.0056
708 BURNING SENSATION 395 0.0056
709 PRODUCT AVAILABILITY ISSUE 128 0.0056
710 FEEDING DISORDER 114 0.0056
711 HEART RATE IRREGULAR 127 0.0056
712 TENDONITIS 87 0.0056
713 PLEURAL EFFUSION 341 0.0056
714 HEPATOMEGALY 55 0.0056
715 EYE DISCHARGE 58 0.0056
716 ECONOMIC PROBLEM 84 0.0055
717 NEUROPATHY PERIPHERAL 527 0.0055
718 CHOLECYSTITIS 66 0.0055
719 CELLULITIS 279 0.0055
720 CHOLESTASIS 106 0.0055
721 WRIST FRACTURE 66 0.0055
722 BREAST CANCER STAGE I 51 0.0055
723 VENTRICULAR EXTRASYSTOLES 57 0.0055
724 ATELECTASIS 53 0.0055
725 SKIN FISSURES 107 0.0055
726 THINKING ABNORMAL 102 0.0055
727 MOOD ALTERED 149 0.0055
728 RIB FRACTURE 112 0.0054
729 SKIN LACERATION 59 0.0054
730 DYSTONIA 105 0.0054
731 CLOSTRIDIUM DIFFICILE INFECTION 118 0.0054
732 EYE INFECTION 61 0.0054
733 APHASIA 163 0.0054
734 NEPHROLITHIASIS 247 0.0054
735 MUSCULOSKELETAL CHEST PAIN 83 0.0054
736 EYE INFLAMMATION 51 0.0053
737 DIVERTICULITIS 148 0.0053
738 GAMMA-GLUTAMYLTRANSFERASE INCREASED 118 0.0053
739 HYPOKINESIA 77 0.0053
740 ROTATOR CUFF SYNDROME 68 0.0053
741 SOPOR 70 0.0053
742 MOVEMENT DISORDER 168 0.0052
743 HOSPITALISATION 803 0.0052
744 MYALGIA 887 0.0052
745 EYE PAIN 294 0.0052
746 DERMATITIS 109 0.0052
747 INCREASED APPETITE 99 0.0052
748 SKIN DISCOLOURATION 238 0.0052
749 SCAR 88 0.0051
750 HEAD INJURY 162 0.0051
751 DISEASE RECURRENCE 242 0.0051
752 BLOOD CREATININE INCREASED 332 0.0051
753 SKIN EXFOLIATION 427 0.0051
754 INTENTIONAL OVERDOSE 324 0.0050
755 EPISTAXIS 377 0.0050
756 BRADYCARDIA 267 0.0050
757 IRRITABILITY 302 0.0050
758 CATARACT 299 0.0050
759 TREMOR 825 0.0050
760 HOT FLUSH 374 0.0050
761 ABSCESS 79 0.0049
762 ABORTION SPONTANEOUS 198 0.0049
763 ALTERED STATE OF CONSCIOUSNESS 107 0.0049
764 EATING DISORDER 105 0.0049
765 HALLUCINATION, VISUAL 104 0.0049
766 PALLOR 134 0.0049
767 SKIN DISORDER 164 0.0049
768 OCULAR HYPERAEMIA 233 0.0049
769 SPEECH DISORDER 254 0.0048
770 PAIN IN JAW 137 0.0048
771 RENAL PAIN 51 0.0048
772 GENERALISED TONIC-CLONIC SEIZURE 79 0.0048
773 MOOD SWINGS 152 0.0048
774 ORTHOSTATIC HYPOTENSION 83 0.0048
775 EYE IRRITATION 273 0.0047
776 BLOOD POTASSIUM INCREASED 77 0.0047
777 SUICIDE ATTEMPT 286 0.0047
778 CARDIOMEGALY 58 0.0047
779 MULTIPLE SCLEROSIS 223 0.0047
780 COLD SWEAT 82 0.0046
781 DELUSION 72 0.0046
782 UNRESPONSIVE TO STIMULI 119 0.0046
783 PARALYSIS 66 0.0046
784 BONE PAIN 269 0.0046
785 HEPATOTOXICITY 102 0.0046
786 COMA 218 0.0046
787 BACTERIAL INFECTION 85 0.0046
788 FEAR 122 0.0045
789 ORAL DISCOMFORT 63 0.0045
790 HAEMATOMA 117 0.0045
791 CYANOSIS 71 0.0045
792 HERPES ZOSTER 259 0.0045
793 POLLAKIURIA 187 0.0045
794 HYPOTHYROIDISM 143 0.0045
795 LOCALISED INFECTION 108 0.0045
796 HAIR COLOUR CHANGES 55 0.0044
797 TREATMENT NONCOMPLIANCE 241 0.0044
798 RASH GENERALISED 114 0.0044
799 APATHY 64 0.0044
800 EYELID OEDEMA 51 0.0044
801 ANAEMIA 829 0.0043
802 RENAL FAILURE 577 0.0043
803 GALLBLADDER DISORDER 77 0.0043
804 RESPIRATORY DISTRESS 118 0.0043
805 ABNORMAL DREAMS 118 0.0043
806 DRUG EXPOSURE DURING PREGNANCY 145 0.0043
807 DEMENTIA 118 0.0042
808 SEROTONIN SYNDROME 81 0.0042
809 TOXICITY TO VARIOUS AGENTS 710 0.0042
810 GLAUCOMA 81 0.0042
811 HYPOGLYCAEMIA 204 0.0042
812 NOCTURIA 51 0.0042
813 GENERALISED OEDEMA 52 0.0042
814 SCHIZOPHRENIA 51 0.0042
815 POST PROCEDURAL COMPLICATION 80 0.0042
816 FAECES DISCOLOURED 90 0.0041
817 HEMIPARESIS 70 0.0041
818 PRODUCT USE COMPLAINT 65 0.0041
819 BONE LOSS 62 0.0041
820 UPPER LIMB FRACTURE 82 0.0041
821 VISION BLURRED 564 0.0041
822 DEVICE RELATED INFECTION 63 0.0041
823 TRANSAMINASES INCREASED 91 0.0041
824 MELAENA 90 0.0041
825 INFLUENZA LIKE ILLNESS 334 0.0041
826 DRUG LEVEL INCREASED 67 0.0040
827 BRAIN OEDEMA 51 0.0040
828 TOOTHACHE 73 0.0040
829 THYROID DISORDER 62 0.0040
830 IMMUNE SYSTEM DISORDER 53 0.0040
831 NERVOUSNESS 210 0.0040
832 STAPHYLOCOCCAL INFECTION 132 0.0040
833 CHOLELITHIASIS 131 0.0040
834 EJECTION FRACTION DECREASED 62 0.0040
835 LIVER FUNCTION TEST ABNORMAL 116 0.0040
836 HYPERGLYCAEMIA 145 0.0040
837 THERAPY INTERRUPTED 284 0.0040
838 ATRIAL FIBRILLATION 386 0.0040
839 FLATULENCE 224 0.0039
840 PRODUCT PRESCRIBING ERROR 94 0.0039
841 BLOOD GLUCOSE INCREASED 742 0.0039
842 BASAL CELL CARCINOMA 61 0.0039
843 ACUTE RESPIRATORY DISTRESS SYNDROME 69 0.0039
844 PNEUMONIA ASPIRATION 97 0.0039
845 RESPIRATORY FAILURE 283 0.0039
846 PULMONARY HYPERTENSION 80 0.0038
847 IMPAIRED WORK ABILITY 82 0.0038
848 DYSSTASIA 112 0.0038
849 DYSGEUSIA 283 0.0038
850 HYPERTHYROIDISM 55 0.0038
851 PULMONARY ARTERIAL HYPERTENSION 55 0.0038
852 DIABETES MELLITUS 289 0.0038
853 INCORRECT DOSE ADMINISTERED 864 0.0038
854 INJECTION SITE SWELLING 290 0.0038
855 BLOOD PRESSURE ABNORMAL 75 0.0038
856 FULL BLOOD COUNT DECREASED 76 0.0038
857 DYSKINESIA 153 0.0038
858 HYPOPHAGIA 96 0.0038
859 CARDIAC ARREST 310 0.0038
860 PULMONARY OEDEMA 168 0.0037
861 INJECTION SITE URTICARIA 92 0.0037
862 THERAPEUTIC RESPONSE UNEXPECTED 167 0.0037
863 SKIN ULCER 96 0.0037
864 AGRANULOCYTOSIS 69 0.0037
865 LEUKOCYTOSIS 67 0.0037
866 HAEMOGLOBIN DECREASED 376 0.0037
867 EMOTIONAL DISTRESS 443 0.0037
868 RENAL IMPAIRMENT 307 0.0037
869 MENTAL DISORDER 158 0.0036
870 BONE DISORDER 66 0.0036
871 PANCYTOPENIA 202 0.0036
872 INTESTINAL OBSTRUCTION 136 0.0036
873 MYOCARDIAL INFARCTION 628 0.0036
874 PSYCHOTIC DISORDER 106 0.0036
875 ENCEPHALOPATHY 88 0.0036
876 WHITE BLOOD CELL COUNT DECREASED 388 0.0036
877 GLYCOSYLATED HAEMOGLOBIN INCREASED 90 0.0036
878 RENAL DISORDER 166 0.0036
879 RENAL INJURY 105 0.0035
880 ABNORMAL BEHAVIOUR 139 0.0035
881 BLOOD BILIRUBIN INCREASED 94 0.0035
882 GASTRIC ULCER 66 0.0035
883 NEUTROPENIA 469 0.0034
884 INJECTION SITE PRURITUS 231 0.0034
885 BONE DENSITY DECREASED 108 0.0034
886 SEPSIS 384 0.0034
887 PLATELET COUNT DECREASED 366 0.0034
888 INJECTION SITE RASH 105 0.0034
889 PRODUCT SUBSTITUTION ISSUE 195 0.0034
890 TOOTH DISORDER 75 0.0034
891 DEAFNESS 88 0.0034
892 DIABETES MELLITUS INADEQUATE CONTROL 59 0.0033
893 NEEDLE ISSUE 97 0.0033
894 ERECTILE DYSFUNCTION 85 0.0033
895 SPINAL FRACTURE 66 0.0033
896 NEUTROPHIL COUNT DECREASED 134 0.0033
897 PERICARDIAL EFFUSION 76 0.0033
898 ABDOMINAL PAIN LOWER 83 0.0033
899 PNEUMOTHORAX 52 0.0033
900 RHABDOMYOLYSIS 136 0.0033
901 ARRHYTHMIA 154 0.0032
902 COMPLETED SUICIDE 266 0.0032
903 DEPRESSED LEVEL OF CONSCIOUSNESS 126 0.0032
904 CARDIO-RESPIRATORY ARREST 133 0.0032
905 LACTIC ACIDOSIS 102 0.0031
906 THERAPY CESSATION 161 0.0031
907 NO ADVERSE EVENT 567 0.0031
908 HERNIA 60 0.0031
909 BLOOD GLUCOSE DECREASED 149 0.0031
910 CARDIAC FAILURE 248 0.0031
911 SURGERY 178 0.0030
912 MULTIPLE ORGAN DYSFUNCTION SYNDROME 86 0.0030
913 NERVOUS SYSTEM DISORDER 94 0.0030
914 MENTAL STATUS CHANGES 83 0.0030
915 EMOTIONAL DISORDER 92 0.0030
916 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 87 0.0030
917 PULMONARY EMBOLISM 280 0.0029
918 INJECTION SITE WARMTH 60 0.0029
919 INJECTION SITE ERYTHEMA 361 0.0029
920 PRODUCT PRESCRIBING ISSUE 62 0.0028
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 575 0.0028
922 MUSCULOSKELETAL DISORDER 54 0.0028
923 SKIN IRRITATION 129 0.0028
924 HYPOACUSIS 121 0.0028
925 HAEMATEMESIS 71 0.0028
926 INJECTION SITE BRUISING 223 0.0028
927 SKIN CANCER 60 0.0028
928 ACUTE MYOCARDIAL INFARCTION 82 0.0028
929 CARDIAC FAILURE CONGESTIVE 223 0.0028
930 SKIN BURNING SENSATION 198 0.0028
931 THROMBOSIS 221 0.0027
932 EXPOSURE VIA SKIN CONTACT 71 0.0027
933 MENTAL IMPAIRMENT 66 0.0027
934 HAEMATURIA 93 0.0027
935 GASTRIC DISORDER 93 0.0027
936 INTERSTITIAL LUNG DISEASE 131 0.0027
937 ERUCTATION 52 0.0027
938 HEPATIC FAILURE 81 0.0027
939 DEEP VEIN THROMBOSIS 173 0.0027
940 ANGINA PECTORIS 76 0.0026
941 INTERNATIONAL NORMALISED RATIO INCREASED 75 0.0026
942 HAEMORRHAGE 274 0.0026
943 TOOTH LOSS 53 0.0026
944 INJECTION SITE PAIN 777 0.0025
945 UNEVALUABLE EVENT 189 0.0025
946 INJECTION SITE MASS 92 0.0025
947 HIP FRACTURE 80 0.0025
948 CEREBRAL HAEMORRHAGE 89 0.0025
949 DRUG EFFECT INCOMPLETE 90 0.0025
950 CONVULSION 140 0.0024
951 CARDIAC DISORDER 229 0.0024
952 PRODUCT DISPENSING ERROR 53 0.0024
953 BLOOD CREATINE PHOSPHOKINASE INCREASED 70 0.0024
954 DIABETIC KETOACIDOSIS 58 0.0024
955 CORONARY ARTERY DISEASE 73 0.0024
956 TARDIVE DYSKINESIA 68 0.0024
957 RESPIRATORY ARREST 66 0.0024
958 ACNE 181 0.0024
959 OSTEONECROSIS 78 0.0024
960 CARDIOVASCULAR DISORDER 60 0.0024
961 GASTROINTESTINAL HAEMORRHAGE 196 0.0023
962 DRUG EFFECT DECREASED 122 0.0023
963 DISEASE PROGRESSION 267 0.0023
964 DRUG DEPENDENCE 359 0.0022
965 METABOLIC ACIDOSIS 71 0.0022
966 LUNG NEOPLASM MALIGNANT 91 0.0022
967 HEPATIC FUNCTION ABNORMAL 80 0.0021
968 PLASMA CELL MYELOMA 83 0.0021
969 PREMATURE BABY 62 0.0021
970 ASCITES 60 0.0020
971 DRUG WITHDRAWAL SYNDROME 178 0.0020
972 MULTIPLE SCLEROSIS RELAPSE 134 0.0020
973 PRODUCT DOSE OMISSION 124 0.0019
974 VISUAL ACUITY REDUCED 62 0.0019
975 VAGINAL HAEMORRHAGE 80 0.0018
976 NEOPLASM PROGRESSION 63 0.0018
977 RENAL FAILURE ACUTE 75 0.0018
978 INJECTION SITE HAEMORRHAGE 141 0.0018
979 GYNAECOMASTIA 53 0.0017
980 CEREBROVASCULAR ACCIDENT 284 0.0017
981 DEVICE ISSUE 148 0.0016
982 ACCIDENTAL EXPOSURE TO PRODUCT 170 0.0016
983 DEATH 1337 0.0016
984 MALIGNANT NEOPLASM PROGRESSION 157 0.0015
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 105 0.0015
986 DEVICE DISLOCATION 63 0.0014
987 DEVICE MALFUNCTION 101 0.0014
988 NEOPLASM MALIGNANT 95 0.0014
989 DEVICE LEAKAGE 61 0.0014
990 BREAST CANCER 116 0.0012
991 DRUG DOSE OMISSION 170 0.0010
992 PRODUCT STORAGE ERROR 89 0.0010
993 DRUG DOSE OMISSION BY DEVICE 69 0.0009